The online submission platform for ERDERA’s Joint Transnational Call 2025 is now live

We are pleased to announce that the platform for submitting project applications for the Joint Transnational Call for Proposals (JTC) 2025 is now officially live. This highly anticipated call invites research teams across Europe and internationally to collaborate on cutting-edge projects aimed at “Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation.” 

How to Use the Platform 

The platform will allow you to: 

  • Register and provide all required personal data for project participants. 
  • Enter your finalised project description.

Access to the platform can be found here.

We strongly recommend registering early to familiarise yourself with the platform’s functionality. A template outlining the required data is available on the ERDERA Funding webpage to assist in your preparation. 

Application Timeline  

The JTC 2025 will follow a two-stage submission process:  

  • 13 February 2025: Pre-proposal submission deadline.  
  • 9 July 2025: Full proposals submission deadline.  

Funding decisions are expected by December 2025. 

For further details, access the updated call documents here. 

News & Updates

You might also be interested in

The multicentre observational study analysed 661 assessments from 219 people with SCA27B to examine disease progression, clinical outcome metrics and demographic or genetic modifiers.
At the “Advancement of Treatments for Rare Diseases” conference in Nicosia, European and national policymakers joined clinicians, researchers, regulators, industry representatives and patient advocates to examine how stronger coordination can translate scientific progress into better prevention, diagnosis, treatment and access to care for people living with rare diseases.
Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.